RxSight, Inc. (RXST) income statement
RXSTNasdaqOphthalmic GoodsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3078% below fair value
$4.47−0.14 (-3.04%)
Close on Nov 20, 2026Market cap $185.92MP/E –Yield –
RxSight, Inc. financial ratios
See a number that looks wrong?